Abstract
A series of multilamellar liposome dispersions was prepared from lipids of soy phosphatidylcholine or hydrogenated soy phosphatidylcholine containing from 0 to 30 mol% of either cholesterol, steary-lamine, or dipalmitoyl phosphatidylglycerol. The liposome dispersions were aerosolized with a Collison nebulizer for 80 min at an output flow rate of 4.7 liters of air/min. The effects of nebulization on the vesicles were determined by monitoring the release of encapsulated 5,6-carboxyfluorescein (CF) from dispersions containing ≈200 µg of total CF, of which 93.1 ± 2.4% (N = 18) was initially encapsulated. In all experiments CF was released from the liposomes while being aerosolized, and this ranged from a mean of 12.7 ± 3.8 to 60.9 ± 1.9% of the encapsulated CF, depending upon the lipid composition. The lipid concentration in the dispersions did not affect the rate or percentage release of CF over a range of ≈0.5 to 50 mg per nebulized dispersion. If liposomes are to be used as drug carriers in an inhalation aerosol a lipid composition should be employed which will minimize the release of encapsulated drug caused by nebulization.
Similar content being viewed by others
REFERENCES
S. P. Newman. Chest 88:152s–160s (1985).
G. K. Crompton. Eur. J. Resp. Dis. 63:101–104 (Suppl. 119) (1982).
K. Agarwal, A. Bali, and C. M. Gupta. Biochim. Biophys. Acta 856:36–40 (1986).
F. Szoka, Jr., and D. Papahadjopoulos. Annu. Rev. Biophys. Bioeng. 9:467–508 (1980).
G. Strauss and H. Hauser. Proc. Natl. Acad. Sci. 83:2422–2426 (1986).
L. M. Crowe, J. H. Crowe, A. Rudolph, C. Womersley, and L. Appel. Arch. Biochem. Biophys. 242:240–247 (1985).
A. Jobe and M. Ikegami. Am. Rev. Resp. Dis. 136:1256–1275 (1987).
H. N. McCullough and R. L. Juliano. J. Nucl. Cancer Inst. 63:727–731 (1979).
R. L. Juliano and H. N. McCullough. J. Pharmacol. Exp. Ther. 214:381–387 (1980).
S. J. Farr, I. W. Kellaway, D. R. Parry-Jones, and S. G. Woolfrey. Int. J. Pharm. 26:303–316 (1985).
K. M. G. Taylor, G. Taylor, I. W. Kellaway, and J. Stevens. Pharm. Res. 6:633–636 (1989).
R. J. Debs, R. M. Straubinger, E. N. Brunette, J. M. Lin, E. J. Lin, A. B. Montgomery, D. S. Friend, and D. P. Papahadjopoulos. Am. Rev. Resp. Dis. 135:731–737 (1987).
B. E. Gilbert, H. R. Six, S. Z. Wilson, P. R. Wyde, and V. Knight. Antivir. Res. 9:355–365 (1988).
P. R. Wyde, H. R. Six, S. Z. Wilson, B. E. Gilbert, and V. Knight. Antimicrob. Agents Chemother. 32:890–895 (1988).
P. J. Mihalko, H. Schreier, and R. M. Abra. In G. Gregoriadis, (ed.), Liposomes as Drug Carriers, J. Wiley & Sons, London 1988, pp. 679–694.
A. Pettenazzo, A. Jobe, M. Ikegami, R. Abra, E. Hogue, and P. Mihalko. Am. Rev. Resp. Dis. 139:752–758 (1989).
R. V. Padmanabhan, R. Gudapaty, I. E. Liener, B. A. Schwartz, and J. R. Hoidal. Am. Rev. Resp. Dis. 132:164–167 (1985).
E. Ralston, L. M. Hjelmeland, R. D. Klausner, J. N. Weinstein, and R. Blumenthal. Biochim. Biophys. Acta 649:133–137 (1981).
F. Olson, C. A. Hunt, F. C. Szoka, W. J. Vail, and D. Papahadjopoulos. Biochim. Biophys. Acta 557:9–23 (1979).
M. Sila, S. Au, and N. Weiner. Biochim. Biophys. Acta 859:165–170 (1986).
M. A. Urbaneja, J. L. Nieva, F. M. Goñi, and A. Alonso. Biochim. Biophys. Acta 904:337–345 (1987).
E. G. Bligh and W. J. Dyer. Can. J. Biochem. Phys. 37:911–917 (1959).
G. Rouser, S. Fleischer, and A. Yamamoto. Lipids 5:494–496 (1970).
K. R. May. Aerosol Sci. 4:235–243 (1973).
J. De Gier, J. G. Mandersloot, and L. L. M. VanDeenen. Biochim. Biophys. Acta. 150:666–675 (1965).
S. M. Johnson. Biochim. Biophys. Acta 307:27–41 (1989).
W. Curatolo, B. Sears, and L. J. Neuringer. Biochim. Biophys. Acta 817:261–270 (1985).
E. Mayhew, M. Ito, and R. Lazo. Exp. Cell. Res. 171:195–202 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niven, R.W., Schreier, H. Nebulization of Liposomes. I. Effects of Lipid Composition. Pharm Res 7, 1127–1133 (1990). https://doi.org/10.1023/A:1015924124180
Issue Date:
DOI: https://doi.org/10.1023/A:1015924124180